Feasibility of a Multdisciplinary Lung Cancer Videoconference between a Peripheral Hospital and a Comprehensive Cancer Centre

Objective: Treatment of lung cancer patients is changing rapidly and new treatment options have emerged in recent years. In 2007, to guarantee the best treatment procedure for lung cancer patients being treated in our peripheral hospital, we decided to introduce an interdisciplinary tumour videoconference between the Haemato-Oncological Day Hospital in Merano and the Comprehensive Cancer Centre Innsbruck. This retrospective analysis aims to describe the feasibility of such a conference. Patients and Methods: Two hundred and three patients with lung cancer treated at the peripheral hospital of Merano between May 2003 until May 2011 were retrospectively analysed. After introduction of the tumour videoconference in 2007, 54% (n = 110) of the patients in this cohort were discussed in the conference. Results: One hundred and four videoconferences were performed. Videoconference was feasible for 110 patients. Radiotherapeutic treatments were prescribed more frequently in patients from the conference group. Overall, major and minor treatment changes were undertaken in 7% (n = 8) and 18% (n = 20), respectively. Conclusion: Interdisciplinary tumour videoconference is feasible between a peripheral hospital and a comprehensive cancer centre. Radiotherapeutic treatment was prescribed more frequently, suggesting that such a conference facilitates the access to cancer-centre-specific treatment modalities. Accordingly, tumour videoconference between a peripheral hospital and a cancer centre is to be recommend.

[1]  R. Kaaks,et al.  Lifestyle and Cancer Risk , 2015, Cancer journal.

[2]  A. Rossi,et al.  First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Amita Sharma,et al.  Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence. , 2012, The Annals of thoracic surgery.

[4]  A. Nicholson,et al.  Non-small-cell lung cancer , 2011, The Lancet.

[5]  Jeffrey W. Clark,et al.  Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. , 2011, The Lancet. Oncology.

[6]  A. Engel,et al.  The effect of a Radiology Conference consultation on cancer patients management. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  Suresh Senan,et al.  European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  David L. Smith,et al.  A Statewide Community Cancer Center Videoconferencing Program , 2008, Annals of Surgical Oncology.

[9]  U. Bogdahn,et al.  Can Telemedicine Contribute to Fulfill WHO Helsingborg Declaration of Specialized Stroke Care? , 2005, Cerebrovascular Diseases.

[10]  J J McAleer,et al.  Broadcast quality teleconferencing for oncology. , 2001, The oncologist.

[11]  Johnston,et al.  The NCI All Ireland Cancer Conference. , 1999, The oncologist.

[12]  G E Gross,et al.  The role of the tumor board in a community hospital , 1987, CA: a cancer journal for clinicians.

[13]  D. Wishart,et al.  The tumor board—How it works in a community hospital , 1977, CA: a cancer journal for clinicians.

[14]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[15]  J. Petty,et al.  Beyond doughnuts: tumor board recommendations influence patient care. , 2002, Journal of cancer education : the official journal of the American Association for Cancer Education.

[16]  Cancer programs approved by the Commission on Cancer of the American College of Surgeons, January, 1, 1981. , 1981, Bulletin of the American College of Surgeons.